2025-06-11-花旗集团-弗勒里（FLRY3）_Fleury（FLRY3.SA）_管理层会议要点_10页_264kb
报告摘要
- Fleury (FLRY3.SA) analysis from Citigroup's investor meeting on June 12, 2025.
- Citigroup maintains a Neutral rating, noting management's confidence in the ongoing recovery of the Brazilian healthcare industry.
- Key long-term strategies include diversifying the payor base, consolidating a portfolio with strong brands, and boosting productivity through AI initiatives.
- Capital allocation is focused on enhancing shareholder returns, with targeted dividend yield of 4.7% and a payout ratio between 80% and 90%.
- Target price is set at R$13.00, with expected stock return of 1.1% and total expected return of 5.8%, based on a DCF valuation.
- Risks include potential slowing of organic growth, execution challenges from recent acquisitions, and increased competition, with calendar effects impacting short-term results.
- Management expects cancellations to remain stable at 1.3-1.4% of sales, while 2Q25 may see a negative calendar impact on sales, but average production per day is expected to drive healthy trends.
展开完整摘要
试读结束，高清完整版pdf/doc/ppt,请点下载
